Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Shkreli's Ponzi Scheme Trifecta: Lies, Deceit And Greed

This article was originally published in Scrip

Executive Summary

With the answer to the big question about Martin Shkreli out of the way – The FBI confirmed it didn't seize his $2m one-of-its-kind album of the American hip-hop group Wu-Tang Clan – what investors and patients likely are wondering is where do his companies, Turing Pharmaceuticals AG and KaloBios Pharmaceuticals Inc., go from here?


Related Content

More Than 'That Old Shkreli Co.,' KaloBios Ready To Innovate, Change Biotech